US pharma major Bristol Myers Squibb has entered into a definitive agreement to acquire Orbital Therapeutics, a privately ...
US biotech major Biogen and RNA medicine specialist Stoke Therapeutics have presented longer-term follow-up analyses from the ...
UK pharma major AstraZeneca announced that it will now invest $4.5 billion in its new manufacturing facility in Virginia, a ...
German pharma major Bayer’s gene therapy subsidiary AskBio today announced initial safety data from the first cohort of ...
Swedish oncology specialist Xspray Pharma has received a complete response letter (CRL) from the US Food and Drug ...
An Expert View from Agnese Cattaneo, Chief Medical Officer at Angelini Pharma.
India-headquartered Lupin has announced its plans for a new state-of-the-art pharmaceutical manufacturing plant in Coral ...
Expedition Therapeutics has closed a $165 million series A financing, just two months after acquiring global rights outside ...
US venture firm Ascenta Capital has closed its inaugural fund at $325 million, marking a significant milestone two years ...
Swiss biopharma firm Idorsia yesterday announced that it has successfully raised 65.6 million francs ($83 million) through ...
Spanish plasma-based medicines producer Grifols announced that Yimmugo, an innovative intravenous immunoglobulin (IVIg) ...
Switzerland-based Ypsomed will establish its first manufacturing facility in the USA, selecting Holly Springs in Wake County, North Carolina, as the location.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback